Deborah L. Mortensen

2.3k total citations
25 papers, 1.6k citations indexed

About

Deborah L. Mortensen is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Deborah L. Mortensen has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Deborah L. Mortensen's work include Growth Hormone and Insulin-like Growth Factors (13 papers), Alzheimer's disease research and treatments (7 papers) and Lipid metabolism and disorders (6 papers). Deborah L. Mortensen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (13 papers), Alzheimer's disease research and treatments (7 papers) and Lipid metabolism and disorders (6 papers). Deborah L. Mortensen collaborates with scholars based in United States, Switzerland and France. Deborah L. Mortensen's co-authors include Ross Clark, Paul J. Fielder, Suhasini Iyer, Saileta Prabhu, Rong Deng, Frank‐Peter Theil, Lena Carlsson, Kenneth Dorshkind, Paula Jardieu and Robert Paul and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Neurology.

In The Last Decade

Deborah L. Mortensen

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah L. Mortensen United States 18 610 503 430 331 206 25 1.6k
Yoshitake Murayama Japan 25 1.3k 2.1× 784 1.6× 268 0.6× 87 0.3× 200 1.0× 47 2.6k
Guy Meno‐Tetang United States 13 419 0.7× 218 0.4× 356 0.8× 150 0.5× 83 0.4× 21 1.2k
Alessandro Corsaro Italy 31 1.4k 2.2× 462 0.9× 334 0.8× 75 0.2× 126 0.6× 72 2.4k
Jens Y. Humrich Germany 24 437 0.7× 429 0.9× 139 0.3× 138 0.4× 1.2k 5.6× 55 2.2k
Hongwei Qian Australia 29 2.0k 3.4× 583 1.2× 233 0.5× 94 0.3× 182 0.9× 55 2.8k
Rossano Lattanzio Italy 29 1.3k 2.1× 369 0.7× 140 0.3× 258 0.8× 274 1.3× 83 2.7k
Jean‐Michel Longpré Canada 21 684 1.1× 197 0.4× 141 0.3× 81 0.2× 80 0.4× 57 1.6k
Mark Fidock United Kingdom 20 807 1.3× 323 0.6× 110 0.3× 54 0.2× 358 1.7× 32 1.6k
Petronila Penela Spain 29 2.2k 3.6× 265 0.5× 104 0.2× 174 0.5× 275 1.3× 54 2.7k
Howard K. Surks United States 20 1.0k 1.7× 421 0.8× 197 0.5× 40 0.1× 144 0.7× 32 1.8k

Countries citing papers authored by Deborah L. Mortensen

Since Specialization
Citations

This map shows the geographic impact of Deborah L. Mortensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah L. Mortensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah L. Mortensen more than expected).

Fields of papers citing papers by Deborah L. Mortensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah L. Mortensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah L. Mortensen. The network helps show where Deborah L. Mortensen may publish in the future.

Co-authorship network of co-authors of Deborah L. Mortensen

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah L. Mortensen. A scholar is included among the top collaborators of Deborah L. Mortensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah L. Mortensen. Deborah L. Mortensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cummings, Jeffrey L., Sharon Cohen, Christopher H. van Dyck, et al.. (2018). ABBY. Neurology. 90(21). e1889–e1897. 182 indexed citations
2.
3.
Kappos, Ludwig, Stephen L. Hauser, Xavier Montalbán, et al.. (2017). Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis (P5.407). Neurology. 88(16_supplement). 2 indexed citations
4.
Cummings, Jeffrey L., Yong‐Yeon Cho, Michael E. Ward, et al.. (2014). O4‐11‐06: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_5). 17 indexed citations
5.
Atwal, Jasvinder K., Christopher Chiu, Deborah L. Mortensen, et al.. (2013). A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 45 indexed citations
6.
Mortensen, Deborah L., Saileta Prabhu, Eric Stefanich, et al.. (2012). Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies. mAbs. 4(6). 724–731. 26 indexed citations
7.
Deng, Rong, Suhasini Iyer, Frank‐Peter Theil, et al.. (2011). Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data. mAbs. 3(1). 61–66. 203 indexed citations
8.
Atwal, Jasvinder K., Yongmei Chen, Cecilia Chiu, et al.. (2011). A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo. Science Translational Medicine. 3(84). 84ra43–84ra43. 214 indexed citations
9.
Boxer, Adam L., Deborah L. Mortensen, Jing Li, et al.. (2010). P4‐082: A Phase I Study With MABT5102A, an Anti‐abeta Antibody, in Patients With Mild to Moderate Alzheimer's Disease. Alzheimer s & Dementia. 6(4S_Part_21). 1 indexed citations
10.
Mortensen, Deborah L., Patricia A. Walicke, Xiaolin Wang, et al.. (2005). Pharmacokinetics and Pharmacodynamics of Multiple Weekly Subcutaneous Efalizumab Doses in Patients With Plaque Psoriasis. The Journal of Clinical Pharmacology. 45(3). 286–298. 47 indexed citations
11.
Lowman, Henry B., Nicholas J. Skelton, Deborah L. Mortensen, et al.. (1998). Molecular Mimics of Insulin-like Growth Factor 1 (IGF-1) for Inhibiting IGF-1:  IGF-Binding Protein Interactions. Biochemistry. 37(25). 8870–8878. 74 indexed citations
12.
Clark, Ross, G. B. Thomas, Deborah L. Mortensen, et al.. (1997). Growth Hormone Secretagogues Stimulate the Hypothalamic-Pituitary-Adrenal Axis and Are Diabetogenic in the Zucker Diabetic Fatty Rat1. Endocrinology. 138(10). 4316–4323. 42 indexed citations
13.
Mortensen, Deborah L., Wesley Won, Jason J. Siu, et al.. (1997). Insulin-Like Growth Factor Binding Protein-1 Induces Insulin Release in the Rat. Endocrinology. 138(5). 2073–2080. 22 indexed citations
14.
Mortensen, Deborah L.. (1997). Insulin-Like Growth Factor Binding Protein-1 Induces Insulin Release in the Rat. Endocrinology. 138(5). 2073–2080. 12 indexed citations
15.
Clark, Ross, Deborah L. Mortensen, Lena Carlsson, et al.. (1996). Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat.. Endocrinology. 137(10). 4308–4315. 56 indexed citations
16.
Clark, Ross, et al.. (1996). The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.. Endocrinology. 137(5). 1904–1912. 34 indexed citations
17.
Clark, Ross, K. C. Olson, Germaine Fuh, et al.. (1996). Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol. Journal of Biological Chemistry. 271(36). 21969–21977. 201 indexed citations
18.
Clark, Ross, et al.. (1995). Growth responses to patterned GH delivery. Endocrine. 3(10). 717–723. 13 indexed citations
19.
Clark, Ross, Deborah L. Mortensen, & Lena Carlsson. (1995). Insulin-like growth factor-1 and growth hormone (GH) have distinct and overlapping anabolic effects in GH-deficient rats. Endocrine. 3(4). 297–304. 25 indexed citations
20.
Mortensen, Deborah L., et al.. (1993). Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.. PubMed. 3(1). 50–2. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitake Murayama Breakdown of academic impact, for papers by Guy Meno‐Tetang Breakdown of academic impact, for papers by Alessandro Corsaro Breakdown of academic impact, for papers by Jens Y. Humrich Breakdown of academic impact, for papers by Hongwei Qian Breakdown of academic impact, for papers by Rossano Lattanzio Breakdown of academic impact, for papers by Jean‐Michel Longpré Breakdown of academic impact, for papers by Mark Fidock Breakdown of academic impact, for papers by Petronila Penela Breakdown of academic impact, for papers by Howard K. Surks
Rankless by CCL
2026